We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
FedEx
FDX
$74B
| $140K | ﹤0.01% |
607
-103,812
| -99% | -$24.4M |
|
3127
TORM
TRMD
$3.05B
| $140K | ﹤0.01% |
15,805
-47,977
| -75% | -$378K |
|
|
YJ
3128
Yunji
YJ
$6.11M
| $139K | ﹤0.01% |
+3,378
| New | +$115K |
|
3129
Eterna Therapeutics
ERNA
$4.21M
| $138K | ﹤0.01% |
9
+5
| +125% | +$94.9K |
|
3130
Alight
ALIT
$523M
| $137K | ﹤0.01% |
695
-5,805
| -89% | -$1.14M |
|
3131
Blend Labs
BLND
$433M
| $137K | ﹤0.01% |
+24,029
| New | +$186K |
|
|
LFT
3132
Lument Finance Trust
LFT
$41.3M
| $137K | ﹤0.01% |
+49,959
| New | +$158K |
|
3133
CALL
Uber
UBER
$144B
| $137K | ﹤0.01% |
+3,800
| New | +$137K |
|
|
ENDP
3134
DELISTED
Endo International plc
ENDP
| $137K | ﹤0.01% |
59,239
-124,555
| -68% | -$365K |
|
3135
Gaotu Techedu
GOTU
$384M
| $136K | ﹤0.01% |
79,204
-1,091,945
| -93% | -$2.08M |
|
3136
Intellicheck
IDN
$73.7M
| $136K | ﹤0.01% |
53,443
+15,171
| +40% | +$55.3K |
|
3137
CALL
Shopify
SHOP
$169B
| $136K | ﹤0.01% |
+2,000
| New | +$164K |
|
|
SLVRW
3138
CALL
DELISTED
SilverSPAC Inc. Warrant
SLVRW
| $136K | ﹤0.01% |
13,996
| – | – |
|
|
YELL
3139
DELISTED
Yellow Corporation Common Stock
YELL
| $135K | ﹤0.01% |
19,447
-22,179
| -53% | -$212K |
|
|
RWT
3140
Redwood Trust
RWT
$585M
| $134K | ﹤0.01% |
+12,723
| New | +$145K |
|
|
CELL
3141
DELISTED
PhenomeX Inc. Common Stock
CELL
| $134K | ﹤0.01% |
18,832
-13,923
| -43% | -$115K |
|
3142
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $133K | ﹤0.01% |
1,300
-13,900
| -91% | -$1.45M |
|
|
RPT
3143
Rithm Property Trust
RPT
$95.8M
| $133K | ﹤0.01% |
+1,893
| New | +$138K |
|
|
UPH.WS
3144
CALL
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
| $131K | ﹤0.01% |
110,395
+60,395
| +121% | +$18.6K |
|
|
MRSN
3145
DELISTED
Mersana Therapeutics
MRSN
| $130K | ﹤0.01% |
+1,307
| New | +$153K |
|
3146
Acumen Pharmaceuticals
ABOS
$165M
| $129K | ﹤0.01% |
32,825
-123,425
| -79% | -$672K |
|
3147
Friedman Industries
FRD
$264M
| $129K | ﹤0.01% |
14,666
-10,367
| -41% | -$94.9K |
|
3148
Fortuna Silver Mines
FSM
$2.55B
| $128K | ﹤0.01% |
33,391
-80,179
| -71% | -$303K |
|
|
SACH
3149
Sachem Capital Corp
SACH
$38.8M
| $125K | ﹤0.01% |
24,317
-218,436
| -90% | -$1.16M |
|
3150
Pulse Biosciences
PLSE
$2.45B
| $124K | ﹤0.01% |
+25,575
| New | +$209K |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.